Open AccessCanagliflozin compared with sitagliptin for patients with type 2 diabetes who do not have adequate glycemic control with metformin plus sulfonylurea: a 52-week randomized trial. Diabetes Care 2013;36:2508–2515
Author(s) -
Guntram Schernthaner,
JL Gross,
J Rosenstock,
M Guarisco,
Minghuan Fu,
Jacqueline Yee,
Mayuko Kawaguchi,
William Canovatchel,
Gary Meininger
Publication year - 2013
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc13-er12a
Subject(s) - medicine , metformin , sulfonylurea , canagliflozin , sitagliptin , glycemic , type 2 diabetes , diabetes mellitus , randomized controlled trial , endocrinology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom